PedAM
Pediatric Disease Annotations & Medicines
| Disease | colorectal neoplasms |
| Phenotype | C0009324|ulcerative colitis |
| Sentences | 9 |
| PubMedID- 24710620 | 5-aminosalicylates use was associated with a reduced risk of colorectal neoplasia in patients with ulcerative colitis (or 0.63; 95%ci 0.48-0.84). |
| PubMedID- 23867875 | Background: aberrant methylation of the eya4 gene (meya4) highly discriminates ulcerative colitis (uc) cases with colorectal neoplasia from uc controls in both tissue and stool. |
| PubMedID- 19685451 | Do 5-asas prevent colorectal neoplasia in patients with ulcerative colitis. |
| PubMedID- 26355468 | Multiyear patterns of serum inflammatory biomarkers and risk of colorectal neoplasia in patients with ulcerative colitis. |
| PubMedID- 24907505 | We included studies on thiopurine exposure and risk of colorectal neoplasia in patients with ulcerative colitis or crohn's disease. |
| PubMedID- 26351379 | Thiopurine therapy reduces the incidence of colorectal neoplasia in patients with ulcerative colitis. |
| PubMedID- 21692821 | Results: primary sclerosing cholangitis increases the risk of colorectal neoplasia in patients with ulcerative colitis; fewer data are available for crohn's disease. |
| PubMedID- 20656250 | Non-polypoid colorectal neoplasms in ulcerative colitis. |
| PubMedID- 21556038 | High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. |
Page: 1